8faacd8dbe8ce76d…

Study
ID: NCT00036114683 bytesFirst seen Jun 12, 20261 collection

Fields

NameValue
briefSummaryThe purpose of this study is to learn if aripiprazole is safe and effective in the treatment of psychosis associated with dementia of the Alzheimer's type.
completionDate2003-08
conditions["Alzheimer Disease"]
enrollmentCountnull
enrollmentTypenull
nctIdNCT00036114
phasePHASE3
sponsorIdotsuka-pharmaceutical-development-commercialization-inc
startDate2000-03
statusCOMPLETED
studyTypeINTERVENTIONAL
titleStudy of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type
urlhttps://clinicaltrials.gov/study/NCT00036114

Canonical JSON

{
  "id": "NCT00036114",
  "type": "Study",
  "data": {
    "briefSummary": "The purpose of this study is to learn if aripiprazole is safe and effective in the treatment of psychosis associated with dementia of the Alzheimer's type.",
    "completionDate": "2003-08",
    "conditions": [
      "Alzheimer Disease"
    ],
    "enrollmentCount": null,
    "enrollmentType": null,
    "nctId": "NCT00036114",
    "phase": "PHASE3",
    "sponsorId": "otsuka-pharmaceutical-development-commercialization-inc",
    "startDate": "2000-03",
    "status": "COMPLETED",
    "studyType": "INTERVENTIONAL",
    "title": "Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type",
    "url": "https://clinicaltrials.gov/study/NCT00036114"
  }
}

Appears in 1 collection

nih/clinical-trials1 version · Jun 12, 2026

Full hash:8faacd8dbe8ce76dd9a3801c31fa2f2a101ac9c18af411fdbc09520855fe9e6f